tiletamine hydrochloride has been researched along with Osteosarcoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, RY; Liu, Z; Qin, YG; Wang, CY; Wang, QY; Zhang, BY; Zhu, LY | 1 |
| Chai, Y; Hua, X; Jiang, C; Wan, D; Wang, T | 1 |
| Liu, L; Qi, XJ; Zhang, EN; Zhong, ZK | 1 |
| Borges, KS; Castro-Gamero, AM; da Silva Silveira, V; de Paula Gomes Queiroz, R; Lira, RC; Scrideli, CA; Tone, LG; Umezawa, K; Valera, FC | 1 |
4 other study(ies) available for tiletamine hydrochloride and Osteosarcoma
| Article | Year |
|---|---|
Glycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of Osteosarcoma.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Cyclohexanones; Enhancer of Zeste Homolog 2 Protein; Humans; Male; Mice; Mitochondria; Nanoparticles; Neoplasm Invasiveness; Neoplasm Metastasis; Osteosarcoma; Phosphorylation; Polycomb Repressive Complex 2; Proto-Oncogene Proteins c-akt; Time Factors; Transfection; Tretinoin | 2015 |
Cell cycle arrest and apoptosis induced by aspidin PB through the p53/p21 and mitochondria-dependent pathways in human osteosarcoma cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Caspase 3; Caspase 9; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cyclohexanones; Female; Heterografts; Humans; Membrane Potential, Mitochondrial; Mice, Nude; Mitochondria; Neoplasm Transplantation; Osteosarcoma; Phloroglucinol; RNA, Small Interfering; S Phase Cell Cycle Checkpoints; Signal Transduction; Tumor Suppressor Protein p53 | 2015 |
Nanomedicine-based combination of gambogic acid and retinoic acid chlorochalcone for enhanced anticancer efficacy in osteosarcoma.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclohexanones; Drug Liberation; Endocytosis; Humans; Kinetics; Nanomedicine; Nanoparticles; Osteosarcoma; Treatment Outcome; Tretinoin; Xanthones | 2016 |
Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Cyclohexanones; Doxorubicin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Methotrexate; Mitotic Index; NF-kappa B; Osteosarcoma; Protein Transport | 2012 |